325
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Choosing treatment options for patients with relapsed/refractory multiple myeloma

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chunling Wang, Zhengmei He, Yuye Shi, Lijuan Zhang, Yue Chen, Zhi Chen & Liang Yu. (2017) Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma. Hematology 22:2, pages 88-92.
Read now

Articles from other publishers (4)

Antonio Gidaro, Roberto Manetti, Alessandro Delitala, Mark Soloski, Giorgio Lambertenghi Deliliers, Dante Castro, Davide Soldini & Roberto Castelli. (2022) Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release. Journal of Clinical Medicine 11:10, pages 2720.
Crossref
Roberto Castelli, Simona Sciara, Giorgio Lambertenghi Deliliers & Giuseppe Pantaleo. (2017) Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study. Annals of Hematology 96:5, pages 779-786.
Crossref
H Jiang, C Acharya, G An, M Zhong, X Feng, L Wang, N Dasilva, Z Song, G Yang, F Adrian, L Qiu, P Richardson, N C Munshi, Y-T Tai & K C Anderson. (2015) SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide. Leukemia 30:2, pages 399-408.
Crossref
Roberto Castelli, Giuseppe Pantaleo, Paolo Gallipoli, Antonio Gidaro, Massimo Arquati, Maddalena A. Wu & Giorgio Lambertenghi Deliliers. (2015) Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma. Anti-Cancer Drugs 26:10, pages 1078-1082.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.